Article
Direct‐to‐consumer genetic testing: good, bad or benign?
24 Nov 2009
Abstract excerpt
A wide variety of genetic tests are now being marketed and sold in direct-to-consumer (DTC) commercial transactions. However, risk information revealed through many DTC testing services, especially those based on emerging genome wide-association studies, has limited predictive value for consumers. Some commentators contend that tests are being marketed prematurely, while others support rapid translation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
